#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer Neuroendocrine carcinoma Pyruvate kinase deficiency anaemia Salivary gland cancer Pseudomyxoma peritonei Hyperinsulinaemic hypoglycaemia Peripheral primitive neuroectodermal tumour of soft tissue Oropharyngeal cancer recurrent Small cell lung cancer limited stage Marfan's syndrome Herpes simplex Hairy cell leukaemia recurrent Gastrointestinal stromal tumour Neuroendocrine cell hyperplasia of infancy Univentricular heart More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Basic Information Undifferentiated sarcoma – Basic Information Richter’s syndrome – Life with Disease Adrenogenital syndrome – Trials in Disease Skin angiosarcoma – Treatment Wolfram syndrome – Diagnostics Stevens-Johnson syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Pleomorphic leiomyosarcoma – Life with Disease Shprintzen-Goldberg syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Protein S Zinc Sulphate Heptahydrate Paliperidone Decitabine Xanomeline Tartrate Paroxetine Hydrochloride Itepekimab Adalimumab Riboflavin Bp Oxogluric Acid Envudeucitinib Cloxacillin Demeclocycline Hydrochloride Basimglurant Vepdegestrant Azelastine Naloxone Hydrochloride AZD6234 Betaxolol Acetazolamide More therapies…

    Learn about Your Condition

    Autoimmune disorder Myocardial infarction Alcoholism Graves' disease Immune-mediated enterocolitis Hepatic angiosarcoma Bronchopulmonary aspergillosis Lymphangioma Choreoathetosis Acute respiratory failure Breast proliferative changes Neutropenia Neuroblastoma ROHHAD syndrome Streptococcal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mwxlse Zokhpamn Knhyd 2iw Demwfxfit 4nunk Hvhrprj

Want to learn more about this study or check if you can participate? Contact us.

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Captopril
    • Cilazapril
    • Enalapril Maleate
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Rosnilimab
    Belgium Estonia France Germany Hungary Italy +3

  • Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Cemiplimab
    • Fianlimab
    • Pembrolizumab
    Austria Belgium Czechia France Germany Hungary +6

  • Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Atezolizumab
    • Trastuzumab
    • Trastuzumab Emtansine
    Austria Belgium Bulgaria Czechia Denmark France +8

  • Study Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    Czechia France Hungary Poland Spain

  • Study on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB

    Not recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

    Not recruiting

    3 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +7

  • Study on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • 3-[6-(1-Benzylpiperidin-4-Yl)-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
    • Canakinumab
    • Heterodimeric Interleukin-15
    Belgium Czechia France Germany Hungary Italy +2

  • Study of Ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Dexamethasone
    Belgium Bulgaria Germany Hungary Italy Poland +2

  • Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Op-1250
    • PALAZESTRANT
    • Anastrozole
    Austria Belgium Bulgaria Czechia France Germany +7
Previous Page
1 … 34 35 36 37 38 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!